Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)

Market Cap	101.15B
Revenue (ttm)	107.87B
Net Income (ttm)	1.92B
Shares Out	85.00M
EPS (ttm)	47.45
PE Ratio	25.08
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,274
Average Volume	307,019
Open	1,175.00
Previous Close	1,175.00
Day's Range	1,175.00 - 1,187.00
52-Week Range	1,003.00 - 2,060.00
Beta	0.49
RSI	48.76
Earnings Date	n/a

About Hwail Pharmaceutical

Hwail Pharmaceutical Co.,Ltd. develops pharmaceutical raw materials in South Korea. It provides raw drug products, finished drug products, and functional health food raw material business. The company was founded in 1974 and is headquartered in Seongnam-si, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 130
• Stock Exchange: KOSDAQ
• Ticker Symbol: 061250

Financial Performance

In 2016, Hwail Pharmaceutical's revenue was 111.52 billion, an increase of 5.08% compared to the previous year's 106.13 billion. Earnings were 6.38 billion, an increase of 17.03%.